We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Thermo Fisher Scientific - Direct Effect Media

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Laparoscopic Closure Device Seals Common Enterotomy

By HospiMedica International staff writers
Posted on 26 Jan 2022
Print article
Image: The LAP IA 60 laparoscopic stapler for intracorporeal anastomosis (Photo courtesy of Seger)
Image: The LAP IA 60 laparoscopic stapler for intracorporeal anastomosis (Photo courtesy of Seger)
An innovative laparoscopic bowel closure device quickly and securely aligns, closes, and staples the common opening for rapid intracorporeal anastomosis.

The Seger Surgical Solutions (Seger; Misgav, Israel) LAP IA 60 is designed to facilitate the laparoscopic closure of two sections of the intestine intracorporeally by engaging a common enterotomy opening of a side-to-side, functional end-to-end gastrointestinal anastomosis using a pair of prongs to stretch the tissue and draw the engaged openings into jaws of the built-in stapler, which then fires two or three rows of staples to close the enterotomy ,without the need for sutures.

The Seger LAP IA 60 device can close the enterotomy laparoscopically in less than two minutes, as compared to suturing, which take up to 15-20 minutes. The small, 2.5 mm wide device, which can be inserted into the abdomen through a standard 12-millimeter trocar, enables surgeons to perform fully laparoscopic bowel anastomoses with improved clinical results, fewer complications such as bowel twisting and surgical site infection (SSI), and with better cosmesis, since smaller incisions are required.

“Laparoscopic bowel resection and anastomosis is preferred over open surgery because of its clinical benefits to the patient. At present, the majority of these resections and anastomoses are performed outside the abdomen; the reason for this is the difficulty and complexity of laparoscopic suturing by surgeons,” stated the company. “Seger Surgical Solutions introduces LAP IA 60, a laparoscopic bowel closure device that improves patient care, provides better outcomes, and reduces health care costs.”

Following bowel resection, the surgeon creates a common opening (enterotomy) to connect the two severed bowel sections via anastomosis. Currently, most procedures are performed extracorporealy, resulting in longer hospital stays due to post-operative complications, including higher subsequent hernia rates due to the midline incisions, increased pain, and worse cosmesis due to larger incisions.

Related Links:
Seger Surgical Solutions


Print article

Channels

Critical Care

view channel
Image: EsoGuard has demonstrated over 90% specificity and 90% sensitivity in identifying Barrett’s Esophagus (Photo courtesy of Lucid Diagnostics)

Biomarker Based Non-Endoscopic Technology Identifies Risk for Esophageal Cancer

Barrett's esophagus (BE) is the benign and treatable precursor condition to esophageal adenocarcinomas (EAC) which is usually diagnosed at an advanced stage and is difficult to treat. Finding BE, a sign... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.